-
Nasdaq outshines Wall St peers on tech boost, earnings glee
By Shristi Achar A and Shashwat Chauhan (Reuters) - The Nasdaq outpaced Wall Street peers on Wednesday, with Tesla leading gains among megacap stocks after its quarterly results, while upbeat earnings reports across... More
-
- Dollar recovers from PMI slump, yen closes in on 155 per dollar
- Shares jump on tech boost; fragile yen on intervention watch
- Futures mostly higher, Tesla pledges "more affordable" EVs - what's moving markets
- Texas Instruments (TXN) jumps on first above-consensus guide in seven years
- Apple's June guidance will miss Street estimates - Barclays
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Enphase Energy tumbles on guidance miss; BMO trims estimates and price target
- NVIDIA (NVDA) to acquire AI platform Run:AI
- JPMorgan is worried about further S&P 500 sell-off potential
- Wedbush trims Tesla PT to $275 but maintains Buy rating after Musk's comments
- Teledyne Technologies (TDY) stock falls after cutting full-year earnings guidance
- HSBC says Microsoft's valuation remains 'attractive'
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Bernstein on Tesla: 'Widespread deployment of FSD is 5 - 10 years away'
- JPMorgan says S&P 500 tactical bounce 'poised to continue'
-
-
Tesla touts acceleration of new models, but Q1 results fall short of estimates
Investing.com -- Tesla jumped in afterhours trade Tuesday as the EV maker's announcement that it was accelerating the launch of new model overshadowed fiscal first-quarter results that fell short of estimates amid waning... More
-
Boeing reports first revenue drop in 7 quarters as deliveries decline
By Abhijith Ganapavaram and Allison Lampert (Reuters) - Boeing on Wednesday reported its first quarterly revenue drop in seven quarters, but the U.S. planemaker beat Wall Street expectations that were lowered after... More
-
Oil prices steady after rallying on US stock decline, business data
By Robert Harvey and Deep Kaushik Vakil LONDON (Reuters) -Brent crude oil prices steadied around $88 a barrel on Wednesday after rallying in the previous session on a surprise fall in U.S. crude... More
-
Yen on the brink, but Tesla pulls back
A look at the day ahead in European and global markets from Tom Westbrook Strong business activity indicators in Europe and an unexpected cooling in the U.S. have carried the euro above $1.07.... More
Latest StreetInsider Headlines
- 10:12 AM
- 10:11 AM
- 10:11 AM
- 10:10 AM
- 10:10 AM
- 10:10 AM Sheppard Mullin Welcomes IP Partner Alex Chung in Washington D.C.
- 10:10 AM Hilton Grand Vacations Unveils 2024 Brand Ambassadors to Headline Exclusive Member Experiences
- 10:10 AM Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
- 10:10 AM Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
- 10:10 AM Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
To See the Full Feed, Get StreetInsider Premium Today
13Fs
- Buffett's Berkshire adds Atlanta Braves stocks, sells GM and Procter & Gamble
- Starboard Value raises stake in Acacia Research, exits Splunk and Papa John's
- Soros fund sells remaining stake in Rivian, buys 1.5M shares of Novo Nordisk in Q3
Accesswire
- BlackStar Receives Corporate Governance Blockchain Patent
- T-Mobile Announces $163 Million in Completed Network Upgrades for Arkansas
- Equispheres Secures $20 Million Investment Round
Analyst Comments
- Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
- Tesla (TSLA) PT Lowered to $120 at HSBC on 'concerns about the timing and scale of prospects'
- Inflation surprise puts AUD in good position - ING
Analyst PT Change
- Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
- Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
- Tesla (TSLA) PT Lowered to $120 at HSBC on 'concerns about the timing and scale of prospects'
Board Changes
- ClearSign Technologies (CLIR) Appoints David Maley to its Board
- Smart for Life (SMFL) Appoints David Trosin to its Board
- Gaming and Leisure Properties (GLPI) Appoints Debra Martin Chase to Board of Directors
Business Wire
- Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
- Hilton Grand Vacations Unveils 2024 Brand Ambassadors to Headline Exclusive Member Experiences
- Sheppard Mullin Welcomes IP Partner Alex Chung in Washington D.C.
Commodities
- Oil prices climb amid US stocks decline, Middle East conflict
- API Shows US Crude, Gasoline Stocks Fell Last Week, Distillates Rose - Reuters
- Analyst comments after global aluminium output recovers
Corporate News
- Grainger (GWW) Raises Quarterly Dividend 10.2% to $2.05; Approves Repurchase of up to 5M Shares
- Marti Technologies (MRT) Ride-Hailing Service Reaches Over 788,000 Riders and Over 145,000 Registered Drivers
- Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287
Cryptocurrency
- Spot Bitcoin ETFs witness 5th consecutive day of outflows as halving imminent
- Bitcoin price today: tests $59k amid Iran-Israel escalation, halving watch
- Explainer-Bitcoin's 'halving': what is it and does it matter?
Dividends
- Grainger (GWW) Raises Quarterly Dividend 10.2% to $2.05; Approves Repurchase of up to 5M Shares
- Textron (TXT) Declares $0.02 Quarterly Dividend; 0.1% Yield
- Dana Incorporated (DAN) Declares $0.10 Quarterly Dividend; 3.2% Yield
Downgrades
- Summit Insights Downgrades Silicon Labs (SLAB) to Hold, 'expect its stock to be an inline performer'
- Summit Insights Downgrades Silicon Labs (SLAB) to Hold, 'expect its stock to be an inline performer'
- Guggenheim Downgrades Enphase Energy (ENPH) to Sell
Earnings
- Capitol Federal Financial (CFFN) Misses Q2 EPS by 1c
- Ribbon Communications (RBBN) Misses Q1 EPS by 2c; offers guidance
- Bok Financial Corp (BOKF) Misses Q1 EPS by 27c
Economic Data
- Durable Goods (Mar P) 2.6% vs 2.5% Expected, Ex-Trans 0.2% vs 0.2%
- MBA Mortgage Applications -2.7% vs 3.3% Prior
- US new home sales rebound to six-month high; rising mortgage rates a concern
Equity Offerings
- Scilex Holding (SCLX) Prices 15M Share Offering at $1/sh
- Zapata AI (ZPTA) Files for Share and Warrant Offering
- Applied DNA Sciences (APDN) Files for Share and Warrant Offering
FDA
- Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287
- Capricor Therapeutics (CAPR) Announces Positive Type-B Meeting with FDA for CAP-1002
- Altamira Therapeutics (CYTO) Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
Fed
- Fed hawks and doves: US central bankers see 'no urgency' to cut
- Fed's Goolsbee: Asked About A Possible Rate Hike If Needed, Says 'Don't Think Anything Is Not On The Table'
- Fed policy on hold because of 'stalled' progress on inflation, Goolsbee says
Globe Newswire
- Fulcrum GT Renews Its Commitment to Els for Autism Foundation
- Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
- Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advance
Guidance
- Ribbon Communications (RBBN) Misses Q1 EPS by 2c; offers guidance
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- PROG Holdings Inc (PRG) Tops Q1 EPS by 9c
Hedge Funds
- Legacy Credit Reports Over 5% Stake in VCI Global (VCIG)
- BofA says there is a continued strength in buybacks
- Turtle Creek Asset Management Responds to Gildan (GIL) Board’s Governance Charade
Insiders' Blog
- 7 Things to Know About Allbirds' (BIRD) Upcoming $2 Billion IPO
- HireRight (HRT) IPO: 9 Things to Know About the Upcoming Offering
- Udemy (UDMY) IPO: 7 Things to Know About Upcoming $4 Billion IPO
IPOs
- Tungray Technologies (TRSG) Closes $5M IPO
- Chinese bubble tea company Chabaidao sees shares tumble in Hong Kong market debut
- Neo-Concept International Group Holdings (NCI) Prices 2.32M Share IPO at $4/sh
Market Check
- Wall St opens higher on tech boost, earnings glee
- Wall Street closes higher as investors digest earnings, megacap outlook
- Wall St stocks end higher with major corporate earnings in view
Mergers and Acquisitions
- NVIDIA (NVDA) to acquire AI platform Run:AI
- NVIDIA (NVDA) has agreed to acquire Run:ai
- Renovaro Biosciences (RENB) to Acquire Cyclomics
New Coverage
- Singular Research Starts Citizens Inc. (CIA) at Buy-Long Term, 'Proven Distribution Growth'
- Craig-Hallum Assumes Guardant Health (GH) at Buy, 'We think that GH is undervalued'
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
Newsfile
- Peter Nobel Descendant of Nobel Family Shares the Mission and Vision of Nobel Sustainability Trust and Nobel DAO at MIT
- Intellabridge Launches Karma iOS App in the Apple App Store to Accelerate Global Impact Through Everyday Banking
- Gate.io Successfully Concludes the Gate.io VC & Web3 Ecosystem Party at TOKEN2049
Press Releases
- Fulcrum GT Renews Its Commitment to Els for Autism Foundation
- Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
- Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
Private Company News
- Brevan Howard Cuts More Than 100 Employees To Reduce Costs - Bloomberg
- Citadel-Backed Prime Brokerage in Talks to Raise Fresh Capital - Bloomberg
- Red Lobster Mulls Filing For Bankruptcy To Fix Balance Sheet - Bloomberg
PRNewswire
- Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
- GRAINGER INCREASES QUARTERLY DIVIDEND BY 10%; REFRESHES SHARE REPURCHASE AUTHORIZATION
- American Association of Critical-care Nurses Publishes Specialty's First Standards for Appropriate Staffing
Reuters
- ASML CEO says US restricts servicing some China equipment, won't hurt earnings
- HSBC says growing Chinese wealth fuels client investments in US
- Exclusive-Russian ministry stress scenario has growth stalling, rouble diving, document shows